Cargando…
Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome
BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is an acute, febrile, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated syndrome, often with cardiohemodynamic dysfunction. Insight into mechanism of disease is still incomplete. OBJECTIVE: Our objective was to a...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530782/ https://www.ncbi.nlm.nih.gov/pubmed/34688775 http://dx.doi.org/10.1016/j.jaci.2021.10.015 |
_version_ | 1784586734991835136 |
---|---|
author | Huang, Janice J. Gaines, Samantha B. Amezcua, Mateo L. Lubell, Tamar R. Dayan, Peter S. Dale, Marissa Boneparth, Alexis D. Hicar, Mark D. Winchester, Robert Gorelik, Mark |
author_facet | Huang, Janice J. Gaines, Samantha B. Amezcua, Mateo L. Lubell, Tamar R. Dayan, Peter S. Dale, Marissa Boneparth, Alexis D. Hicar, Mark D. Winchester, Robert Gorelik, Mark |
author_sort | Huang, Janice J. |
collection | PubMed |
description | BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is an acute, febrile, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated syndrome, often with cardiohemodynamic dysfunction. Insight into mechanism of disease is still incomplete. OBJECTIVE: Our objective was to analyze immunologic features of MIS-C patients compared to febrile controls (FC). METHODS: MIS-C patients were defined by narrow criteria, including having evidence of cardiohemodynamic involvement and no macrophage activation syndrome. Samples were collected from 8 completely treatment-naive patients with MIS-C (SARS-CoV-2 serology positive), 3 patients with unclassified MIS-C–like disease (serology negative), 14 FC, and 5 MIS-C recovery (RCV). Three healthy controls (HCs) were used for comparisons of normal range. Using spectral flow cytometry, we assessed 36 parameters in antigen-presenting cells (APCs) and 29 in T cells. We used biaxial analysis and uniform manifold approximation and projection (UMAP). RESULTS: Significant elevations in cytokines including CXCL9, M-CSF, and IL-27 were found in MIS-C compared to FC. Classic monocytes and type 2 dendritic cells (DCs) were downregulated (decreased CD86, HLA-DR) versus HCs; however, type 1 DCs (CD11c(+)CD141(+)CLEC9A(+)) were highly activated in MIS-C patients versus FC, expressing higher levels of CD86, CD275, and atypical conventional DC markers such as CD64, CD115, and CX3CR1. CD169 and CD38 were upregulated in multiple monocyte subtypes. CD56(dim)/CD57(−)/KLRG(hi)/CD161(+)/CD38(−) natural killer (NK) cells were a unique subset in MIS-C versus FC without macrophage activation syndrome. CONCLUSION: Orchestrated by complex cytokine signaling, type 1 DC activation and NK dysregulation are key features in the pathophysiology of MIS-C. NK cell findings may suggest a relationship with macrophage activation syndrome, while type 1 DC upregulation implies a role for antigen cross-presentation. |
format | Online Article Text |
id | pubmed-8530782 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Academy of Allergy, Asthma & Immunology |
record_format | MEDLINE/PubMed |
spelling | pubmed-85307822021-10-22 Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome Huang, Janice J. Gaines, Samantha B. Amezcua, Mateo L. Lubell, Tamar R. Dayan, Peter S. Dale, Marissa Boneparth, Alexis D. Hicar, Mark D. Winchester, Robert Gorelik, Mark J Allergy Clin Immunol Covid-19 BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is an acute, febrile, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated syndrome, often with cardiohemodynamic dysfunction. Insight into mechanism of disease is still incomplete. OBJECTIVE: Our objective was to analyze immunologic features of MIS-C patients compared to febrile controls (FC). METHODS: MIS-C patients were defined by narrow criteria, including having evidence of cardiohemodynamic involvement and no macrophage activation syndrome. Samples were collected from 8 completely treatment-naive patients with MIS-C (SARS-CoV-2 serology positive), 3 patients with unclassified MIS-C–like disease (serology negative), 14 FC, and 5 MIS-C recovery (RCV). Three healthy controls (HCs) were used for comparisons of normal range. Using spectral flow cytometry, we assessed 36 parameters in antigen-presenting cells (APCs) and 29 in T cells. We used biaxial analysis and uniform manifold approximation and projection (UMAP). RESULTS: Significant elevations in cytokines including CXCL9, M-CSF, and IL-27 were found in MIS-C compared to FC. Classic monocytes and type 2 dendritic cells (DCs) were downregulated (decreased CD86, HLA-DR) versus HCs; however, type 1 DCs (CD11c(+)CD141(+)CLEC9A(+)) were highly activated in MIS-C patients versus FC, expressing higher levels of CD86, CD275, and atypical conventional DC markers such as CD64, CD115, and CX3CR1. CD169 and CD38 were upregulated in multiple monocyte subtypes. CD56(dim)/CD57(−)/KLRG(hi)/CD161(+)/CD38(−) natural killer (NK) cells were a unique subset in MIS-C versus FC without macrophage activation syndrome. CONCLUSION: Orchestrated by complex cytokine signaling, type 1 DC activation and NK dysregulation are key features in the pathophysiology of MIS-C. NK cell findings may suggest a relationship with macrophage activation syndrome, while type 1 DC upregulation implies a role for antigen cross-presentation. American Academy of Allergy, Asthma & Immunology 2022-03 2021-10-22 /pmc/articles/PMC8530782/ /pubmed/34688775 http://dx.doi.org/10.1016/j.jaci.2021.10.015 Text en © 2021 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Covid-19 Huang, Janice J. Gaines, Samantha B. Amezcua, Mateo L. Lubell, Tamar R. Dayan, Peter S. Dale, Marissa Boneparth, Alexis D. Hicar, Mark D. Winchester, Robert Gorelik, Mark Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome |
title | Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome |
title_full | Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome |
title_fullStr | Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome |
title_full_unstemmed | Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome |
title_short | Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome |
title_sort | upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome |
topic | Covid-19 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530782/ https://www.ncbi.nlm.nih.gov/pubmed/34688775 http://dx.doi.org/10.1016/j.jaci.2021.10.015 |
work_keys_str_mv | AT huangjanicej upregulationoftype1conventionaldendriticcellsimplicatesantigencrosspresentationinmultisysteminflammatorysyndrome AT gainessamanthab upregulationoftype1conventionaldendriticcellsimplicatesantigencrosspresentationinmultisysteminflammatorysyndrome AT amezcuamateol upregulationoftype1conventionaldendriticcellsimplicatesantigencrosspresentationinmultisysteminflammatorysyndrome AT lubelltamarr upregulationoftype1conventionaldendriticcellsimplicatesantigencrosspresentationinmultisysteminflammatorysyndrome AT dayanpeters upregulationoftype1conventionaldendriticcellsimplicatesantigencrosspresentationinmultisysteminflammatorysyndrome AT dalemarissa upregulationoftype1conventionaldendriticcellsimplicatesantigencrosspresentationinmultisysteminflammatorysyndrome AT boneparthalexisd upregulationoftype1conventionaldendriticcellsimplicatesantigencrosspresentationinmultisysteminflammatorysyndrome AT hicarmarkd upregulationoftype1conventionaldendriticcellsimplicatesantigencrosspresentationinmultisysteminflammatorysyndrome AT winchesterrobert upregulationoftype1conventionaldendriticcellsimplicatesantigencrosspresentationinmultisysteminflammatorysyndrome AT gorelikmark upregulationoftype1conventionaldendriticcellsimplicatesantigencrosspresentationinmultisysteminflammatorysyndrome |